Project Grant HT94252510077
Award Date
3/1/25
Completion Date
2/28/27
Dollars Obligated
$362K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Storrs, CT 06269, USA
Similar Awards
This federal Project Grant award of $2,940,000.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research by the University of Connecticut Health Center (UCHC) to transform care for extremity composite injuries through innovations in regenerative medicine and translational research. The award, effective from November 1, 2024 to October 31, 2027, will fund UCHC's efforts to develop advanced medical solutions for military...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...
This federal Project Grant award of $1,557,266 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The funding supports advanced biomedical research at the University of California, Los Angeles (UCLA) to elucidate the molecular pathways by which proinflammatory microbes induce the development of interstitial cystitis. The research will be conducted over a 4-year period from March 1, 2025 to February 28, 2029. As a leading...
This $460,279 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Yale University to investigate the "Loss of Proteostasis and Vascular Amyloidosis". The research, conducted from February 2025 to February 2027, aims to transform healthcare for military service members and the general public through innovative and impactful research. Yale University is a...
The U.S. Department of the Army Medical Command awarded a $670,917 Project Grant (CFDA 12.420 - Military Medical Research and Development) to Yale University on June 15, 2025, with a completion date of June 14, 2027. The grant supports advanced biomedical research focused on exploiting METTL3 inhibition-induced dysregulation of DNA repair in the treatment of leukemia. The research aims to transform healthcare for military service members and the broader public through innovative and impactful...
This $859,773 federal Project Grant was awarded on May 1, 2025 by the Defense Health Agency to Yale University under the Military Medical Research and Development (CFDA 12.420) program. The funding will support a 3-year research project focused on investigating biomarkers and targets related to the progression of leptomeningeal disease from non-small cell lung cancer brain metastasis. The award enables Yale University to conduct advanced biomedical research that aims to transform healthcare...
The U.S. Department of the Army Medical Command awarded a $249,612 project grant to Yale University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "UNRAVELING THE CAUSAL IMPACT OF MS-ASSOCIATED GENETIC VARIANTS IN T CELL IMMUNE TOLERANCE", aims to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant supports a 2-year research project from...
Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This federal Project Grant award of $1,009,054 from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) supports research to discover and therapeutically target endogenous retroviruses in clear cell renal cell carcinoma. The award recipient is Yale University, a private research university with expertise in medical research, healthcare, and technology development. The performance period is from September 1, 2025 to August 31, 2029. This grant is...
This Project Grant award, with a total funding of $5,963,305.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the continued clinical development of a novel pleural and tracheal sealant. The primary award recipient is the University of Vermont & State Agricultural College. A sub-award of an unspecified amount was provided to the University of Connecticut Health Center to support this research effort. The funding will...